Drug Profile
Lipase - Altus Pharmaceuticals
Alternative Names: TheraCLEC LipaseLatest Information Update: 28 Oct 2021
Price :
$50
*
At a glance
- Originator Altus Pharmaceuticals
- Class Anti-inflammatories; Carboxylic ester hydrolases; Pancreatic enzymes; Recombinant proteins
- Mechanism of Action Lipase replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Pancreatic disorders
Most Recent Events
- 16 Dec 2002 Discontinued - Preclinical for Pancreatic disorders in USA (PO)
- 08 Dec 1998 Preclinical development for Pancreatic disorders in USA (PO)